This content is machine translated Modern system therapeutics for hidradenitis suppurativa Immunological dysregulation in the sights of several biologics and “small molecules” The approval of anti-TNF and anti-IL-17 antibody therapies for moderate to severe courses of hidradenitis suppurativa has significantly improved the drug treatment options for this debilitating and potentially mutilating disease...…
